
Grujel-A Tablet
Marketer
Vernoxy Pharma Pvt Ltd
Salt Composition
Aspirin (150mg) + Clopidogrel (75mg)
Overview Grujel-A Tablet
CardioGuard combines two antithrombotic agents to inhibit the development of dangerous blood clots within blood vessels. Prescribed to mitigate the risk of heart attack or stroke in patients with cardiac conditions, it's also indicated for acute coronary syndrome management. CardioGuard tablets should be ingested with food daily at the same time for optimal efficacy. Follow your physician's prescribed dosage and schedule, maintaining consistent intervals. Regular timing enhances adherence. Treatment length and dosage vary depending on the condition being treated; complete the full course regardless of symptom improvement. Adopting a healthy lifestyle—including a low-fat diet, regular exercise, and smoking cessation—can enhance treatment response. Potential side effects include dyspepsia, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption is generally discouraged. Inform your doctor of any pre-existing liver or kidney conditions, pregnancy (current or planned), or breastfeeding before commencing treatment. Always disclose all other medications you are using to your healthcare provider, as interactions are possible.
Primary Ingredients of Grujel-A Tablet
No text provided. Please provide the text you wish me to rewrite.
Uses of Grujel-A Tablet
Preventing heart attacks and strokes; managing acute coronary syndrome.
Major Benefits of Grujel-A Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Grujel-A Tablet with a meal.
Common Side effects of Grujel-A Tablet:
- Bruise
- Gastrointestinal bleeding
- Increased bleeding tendency
- Nosebleeds
How to use Grujel-A Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Grujel-A Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer Grujel-A with a meal.
How Grujel-A Tablet works:
Aspirin and Clopidogrel, combined in Grujel-A tablets, offer dual antiplatelet action to help prevent heart attacks. This medication inhibits platelet aggregation, thus reducing the risk of dangerous clot formation. It's also indicated for the management of acute coronary syndrome.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Grujel-A Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Grujel-A Tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptionally perilous circumstances, a physician might prescribe it if the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Grujel-A Tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Grujel-A Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Grujel-A Tablets cautiously, potentially requiring dosage modification under medical supervision. Grujel-A Tablets are contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should exercise caution when using Grujel-A Tablets, as dosage modification may be necessary. Individuals with severe hepatic dysfunction should avoid Grujel-A Tablets; physician consultation is advised.
What if you forget to take Grujel-A Tablet :
Should you forget to take a Grujel-A Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Grujel-A Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
